CLDX icon

Celldex Therapeutics

135 hedge funds and large institutions have $1.31B invested in Celldex Therapeutics in 2014 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 52 increasing their positions, 43 reducing their positions, and 37 closing their positions.

Holders
135
Holders Change
-22
Holders Change %
-14.01%
% of All Funds
3.88%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
16
Increased
52
Reduced
43
Closed
37
Calls
$16.9M
Puts
$33.9M
Net Calls
-$17M
Net Calls Change
-$8.92M
Name Holding Trade Value Shares
Change
Shares
Change %
HCM
151
Highbridge Capital Management
New York
-$963K -3,633 Closed
SGAM
152
Smith Group Asset Management
Texas
-$901K -3,399 Closed
Los Angeles Capital Management
153
Los Angeles Capital Management
California
-$646K -2,435 Closed
SG Americas Securities
154
SG Americas Securities
New York
-$511K -1,929 Closed
AGM
155
Alpine Global Management
New York
-$442K -1,667 Closed
SGH
156
Schonfeld Group Holdings
New York
-$432K -1,631 Closed
QIM
157
Quantitative Investment Management
Virginia
-$379K -1,433 Closed
HI
158
HBK Investments
Texas
-$316K -1,191 Closed
SO
159
STRS Ohio
Ohio
-$269K -1,013 Closed
SCM
160
Sigma Capital Management
Connecticut
-$265K -1,000 Closed
GCP
161
GSA Capital Partners
United Kingdom
-$213K -803 Closed
EMG
162
Ellington Management Group
Connecticut
-$182K -687 Closed
Wellington Management Group
163
Wellington Management Group
Massachusetts
-$177K -668 Closed
FMT
164
First Mercantile Trust
Tennessee
-$157K -593 Closed
WAM
165
Wolverine Asset Management
Illinois
-$107K -407 Closed
TRCT
166
Tower Research Capital (TRC)
New York
-$55K -208 Closed
GT
167
Glenmede Trust
Pennsylvania
-$31K -120 Closed
SFSIG
168
San Francisco Sentry Investment Group
California
-$27K -100 Closed
M&T Bank
169
M&T Bank
New York
-$1K -4 Closed